Ausgabe 4/2023
Inhalt (15 Artikel)
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”
Heli Patel, Steven R. Feldman
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology
Ashley M. Snyder, Suephy C. Chen, Mary-Margaret Chren, Laura K. Ferris, LaVar D. Edwards, Robert A. Swerlick, Nicholas D. Flint, Amy M. Cizik, Rachel Hess, Jacob Kean, Aaron M. Secrest
Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review
Adam Daunton, Matthew Harries, Rodney Sinclair, Ralf Paus, Antonella Tosti, Andrew Messenger
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions
Dennis Niebel, Luka de Vos, Tanja Fetter, Christine Brägelmann, Jörg Wenzel
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists
Aditya K. Gupta, Mesbah Talukder, Ted Rosen, Vincent Piguet
Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management
Rose Parisi, Hemali Shah, Alexander A. Navarini, Beda Muehleisen, Michael Ziv, Neil H. Shear, Roni P. Dodiuk-Gad
Climate Change, Skin Health, and Dermatologic Disease: A Guide for the Dermatologist
Annika Belzer, Eva Rawlings Parker
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
Linda Stein Gold, Diamant Thaçi, Jacob P. Thyssen, Melinda Gooderham, Vivian Laquer, Angela Moore, Chitra R. Natalie, Fangyi Zhao, Eric Meskimen, Hany Elmaraghy, Sonia Montmayeur, Gaia Gallo, Gemma Jimenez, Marjolein de Bruin-Weller
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
Eric L. Simpson, Jonathan I. Silverberg, Jacob P. Thyssen, Manuelle Viguier, Diamant Thaçi, Marjolein de Bruin-Weller, Stephan Weidinger, Gary Chan, Marco DiBonaventura, Pinaki Biswas, Claire Feeney, Christopher Koulias, Michael J. Cork
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study
Lawrence F. Eichenfield, Richard G. Gower, JinHua Xu, Maryam S. Alam, John C. Su, Daniela E. Myers, Paul Sanders, Bonnie Vlahos, Chuanbo Zang, Jar Lan, John Werth
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis
Bertrand ShengYang Lian, Judy H. Ha, Rehena Sultana, Linus Chong En Chan, Karen Jui Lin Choo, Yi Wei Yeo, Haur Yueh Lee
Automated Facial Acne Lesion Detecting and Counting Algorithm for Acne Severity Evaluation and Its Utility in Assisting Dermatologists
Dong Hyo Kim, Sukkyu Sun, Soo Ick Cho, Hyoun-Joong Kong, Ji Won Lee, Jun Hyo Lee, Dae Hun Suh
Eosinophil–Lymphocyte Ratio, Eosinophil–Neutrophil Ratio, and Eosinophil–Monocyte Ratio in Chronic and Severe Urticaria
Sarah Weissmann, Nitzan Burrack, Amit Shira Babyev, Michal Gordon, Inbal Golan-Tripto, Amir Horev
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials
Jonathan I. Silverberg, Charles W. Lynde, Katrina Abuabara, Cataldo Patruno, Anna de Benedetto, Haixin Zhang, Ryan B. Thomas, Gaëlle Bégo-Le-Bagousse, Faisal A. Khokhar, Jignesh Vakil, Ainara Rodríguez Marco, Noah A. Levit